Do older patients benefit from heart failure therapies?

About this episode

The episode discusses the benefits of heart failure therapies in older patients and the associated adverse events.

In this episode of the Heart podcast, Digital Media Editor Professor James Rudd is joined by Dr Elinor Tan from the National University of Singapore. They discuss her team's systematic review and meta-analysis of guideline-directed medical therapies in older patients with heart failure and reduced ejection fraction. They wanted to understand whether this patient group still benefits from such therapies and the profile of adverse events. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper:https://heart.bmj.com/content/early/2026/02/11/heartjnl-2025-326305

People in this episode

Host: Professor James Rudd

Guest: Dr Elinor Tan

Topics covered

• heart failure
• older patients
• medical therapies
• ejection fraction
• adverse events

Keywords

• heart failure
• older patients
• medical therapies
• ejection fraction
• adverse events

Mentioned in this episode

Organizations: National University of Singapore, BMJ Group

Books & works: systematic review and meta-analysis, guideline-directed medical therapies

More episodes of Heart Podcast

• Heart failure with preserved ejection fraction plus AF - challenges and opportunities · June 2, 2026 · 31 min
• Can routine cardiac CT in patients with acute coronary syndrome and prior bypass grafts improve clinical decisions? · May 19, 2026 · 15 min
• Simulation training in Cardiology - a missed opportunity? · April 21, 2026 · 18 min
• The natural history of aortic regurgitation · April 7, 2026 · 21 min
• Current and emerging treatments for cardiac amyloidosis · March 24, 2026 · 21 min
• Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease · March 10, 2026 · 12 min